Alnylam Pharmaceuticals revenue

Alnylam Pharmaceuticals revenue increased from $0 in 2017 to $74.9 million in 2018, a NaN% increase.

Annual Revenue ($)

Alnylam Pharmaceuticals revenue was $74.91 m in FY, 2018

Quarterly Revenue ($)

FY, 2018
Revenue$74.91 m
Growth
Q3, 2018Q1, 2019Q2, 2019
Revenue$2.07 m$33.29 m$44.71 m

Annual Growth Rate (%)